Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 174

1.

Predictors of quality of care and survival in a three-state cohort of locally advanced cervical cancer patients and development of a predictive model to identify women at risk of incomplete treatment.

Schad MD, Moore J, Camacho F, Anderson RT, Cantrell LA, Showalter TN.

Medicine (Baltimore). 2019 Aug;98(33):e16874. doi: 10.1097/MD.0000000000016874.

2.

Prediction of Risk of Death for Patients Starting Dialysis: A Systematic Review and Meta-Analysis.

Anderson RT, Cleek H, Pajouhi AS, Bellolio MF, Mayukha A, Hart A, Hickson LJ, Feely MA, Wilson ME, Giddings Connolly RM, Erwin PJ, Majzoub AM, Tangri N, Thorsteinsdottir B.

Clin J Am Soc Nephrol. 2019 Aug 7;14(8):1213-1227. doi: 10.2215/CJN.00050119. Epub 2019 Jul 30.

PMID:
31362990
3.

Experiences with cancer survey in China.

Yao N, Zhang N, Wang J, Anderson RT, Liu X, Lyu J, Du X, Sun X.

Cancer. 2019 Sep 1;125(17):3068-3078. doi: 10.1002/cncr.32164. Epub 2019 May 8.

PMID:
31067359
4.

Risk factors for poor health-related quality of life in cancer survivors with multiple chronic conditions: exploring the role of treatment burden as a mediator.

Eton DT, Anderson RT, Cohn WF, Kennedy EM, St Sauver JL, Bucknell BJ, Ruddy KJ.

Patient Relat Outcome Meas. 2019 Mar 21;10:89-99. doi: 10.2147/PROM.S191480. eCollection 2019.

5.

Disparities in Lung Cancer Screening Availability: Lessons From Southwest Virginia.

Martin AN, Hassinger TE, Kozower BD, Camacho F, Anderson RT, Yao N.

Ann Thorac Surg. 2019 Aug;108(2):412-416. doi: 10.1016/j.athoracsur.2019.03.003. Epub 2019 Apr 2.

PMID:
30951691
6.

Challenges, Considerations, and Principles to Guide Trials of Combination Therapies for Chronic Hepatitis B Virus.

Anderson RT, Lim SG, Mishra P, Josephson F, Donaldson E, Given B, Miller V.

Gastroenterology. 2019 Feb;156(3):529-533.e4. doi: 10.1053/j.gastro.2018.11.062. Epub 2018 Dec 4. Review. No abstract available.

PMID:
30529300
7.

Individual, Social, and Societal Correlates of Health-Related Quality of Life Among African American Survivors of Ovarian Cancer: Results from the African American Cancer Epidemiology Study.

Anderson RT, Peres LC, Camacho F, Bandera EV, Funkhouser E, Moorman PG, Paddock LE, Peters ES, Abbott SE, Alberg AJ, Barnholtz-Sloan J, Bondy M, Cote ML, Schwartz AG, Terry P, Schildkraut JM.

J Womens Health (Larchmt). 2019 Feb;28(2):284-293. doi: 10.1089/jwh.2018.7025. Epub 2018 Oct 10.

PMID:
30307782
8.

Obesity and mortality after locoregional breast cancer diagnosis.

Moore AH, Trentham-Dietz A, Burns M, Gangnon RE, Greenberg CC, Vanness DJ, Hampton J, Wu XC, Anderson RT, Lipscomb J, Kimmick GG, Cress R, Wilson JF, Sabatino SA, Fleming ST.

Breast Cancer Res Treat. 2018 Dec;172(3):647-657. doi: 10.1007/s10549-018-4932-6. Epub 2018 Aug 29.

PMID:
30159788
9.

Indigenous communities, groundwater opportunities.

Womble P, Perrone D, Jasechko S, Nelson RL, Szeptycki LF, Anderson RT, Gorelick SM.

Science. 2018 Aug 3;361(6401):453-455. doi: 10.1126/science.aat6041. No abstract available.

PMID:
30072527
10.

The Role of Provider Characteristics in the Selection of Surgery or Radiation for Localized Prostate Cancer and Association With Quality of Care Indicators.

Satkunasivam R, Lo M, Stern M, Gill IS, Fleming S, Wu XC, Anderson RT, Thompson TD, Hamilton AS.

Am J Clin Oncol. 2018 Apr 17. doi: 10.1097/COC.0000000000000442. [Epub ahead of print]

PMID:
29668486
11.

A common mechanism of proteasome impairment by neurodegenerative disease-associated oligomers.

Thibaudeau TA, Anderson RT, Smith DM.

Nat Commun. 2018 Mar 15;9(1):1097. doi: 10.1038/s41467-018-03509-0.

12.

Validating the Patient Experience with Treatment and Self-Management (PETS), a patient-reported measure of treatment burden, in people with diabetes.

Rogers EA, Yost KJ, Rosedahl JK, Linzer M, Boehm DH, Thakur A, Poplau S, Anderson RT, Eton DT.

Patient Relat Outcome Meas. 2017 Nov 9;8:143-156. doi: 10.2147/PROM.S140851. eCollection 2017.

13.

Risk of cancer death by comorbidity severity and use of adjuvant chemotherapy among women with locoregional breast cancer.

Kimmick GG, Li X, Fleming ST, Sabatino SA, Wilson JF, Lipscomb J, Cress R, Bergom C, Anderson RT, Wu XC; Written on behalf of the Center for Disease Control and Prevention National Program of Cancer Registry Patterns of Care Study Group.

J Geriatr Oncol. 2018 May;9(3):214-220. doi: 10.1016/j.jgo.2017.11.004. Epub 2017 Nov 23.

PMID:
29174187
14.

Healthcare provider relational quality is associated with better self-management and less treatment burden in people with multiple chronic conditions.

Eton DT, Ridgeway JL, Linzer M, Boehm DH, Rogers EA, Yost KJ, Finney Rutten LJ, Sauver JL St, Poplau S, Anderson RT.

Patient Prefer Adherence. 2017 Sep 26;11:1635-1646. doi: 10.2147/PPA.S145942. eCollection 2017.

15.

Racial and Socioeconomic Disparities Are More Pronounced in Inflammatory Breast Cancer Than Other Breast Cancers.

Denu RA, Hampton JM, Currey A, Anderson RT, Cress RD, Fleming ST, Lipscomb J, Wu XC, Wilson JF, Trentham-Dietz A.

J Cancer Epidemiol. 2017;2017:7574946. doi: 10.1155/2017/7574946. Epub 2017 Aug 15.

16.

Impact of patient race and geographical factors on initiation and adherence to adjuvant endocrine therapy in medicare breast cancer survivors.

Camacho FT, Tan X, Alcalá HE, Shah S, Anderson RT, Balkrishnan R.

Medicine (Baltimore). 2017 Jun;96(24):e7147. doi: 10.1097/MD.0000000000007147.

17.

The Proteasomal ATPases Use a Slow but Highly Processive Strategy to Unfold Proteins.

Snoberger A, Anderson RT, Smith DM.

Front Mol Biosci. 2017 Apr 4;4:18. doi: 10.3389/fmolb.2017.00018. eCollection 2017.

18.

The Effects of Hospital Characteristics on Delays in Breast Cancer Diagnosis in Appalachian Communities: A Population-Based Study.

Louis CJ, Clark JR, Hillemeier MM, Camacho F, Yao N, Anderson RT.

J Rural Health. 2018 Feb;34 Suppl 1:s91-s103. doi: 10.1111/jrh.12226. Epub 2017 Jan 19.

19.

Does gender bias in cardiac stress testing still exist? A videographic analysis nested in a randomized controlled trial.

Nestler DM, Gilani WI, Anderson RT, Bellolio MF, Branda ME, LeBlanc A, Phelan S, Campbell RL, Hess EP.

Am J Emerg Med. 2017 Jan;35(1):29-35. doi: 10.1016/j.ajem.2016.09.054. Epub 2016 Sep 30.

PMID:
27825694
20.

Geographic disparities in adherence to adjuvant endocrine therapy in Appalachian women with breast cancer.

Tan X, Camacho F, Marshall VD, Donohoe J, Anderson RT, Balkrishnan R.

Res Social Adm Pharm. 2017 Jul - Aug;13(4):796-810. doi: 10.1016/j.sapharm.2016.08.004. Epub 2016 Aug 25.

21.

Development and validation of the Patient Experience with Treatment and Self-management (PETS): a patient-reported measure of treatment burden.

Eton DT, Yost KJ, Lai JS, Ridgeway JL, Egginton JS, Rosedahl JK, Linzer M, Boehm DH, Thakur A, Poplau S, Odell L, Montori VM, May CR, Anderson RT.

Qual Life Res. 2017 Feb;26(2):489-503. doi: 10.1007/s11136-016-1397-0. Epub 2016 Aug 26.

22.

Finite element analysis of a pseudoelastic compression-generating intramedullary ankle arthrodesis nail.

Anderson RT, Pacaccio DJ, Yakacki CM, Carpenter RD.

J Mech Behav Biomed Mater. 2016 Sep;62:83-92. doi: 10.1016/j.jmbbm.2016.04.037. Epub 2016 May 4.

PMID:
27179767
23.

Determinants of Quality Care and Mortality for Patients With Locally Advanced Cervical Cancer in Virginia.

Showalter TN, Camacho F, Cantrell LA, Anderson RT.

Medicine (Baltimore). 2016 Feb;95(8):e2913. doi: 10.1097/MD.0000000000002913.

24.

Spatial Access to Primary Care Providers in Appalachia: Evaluating Current Methodology.

Donohoe J, Marshall V, Tan X, Camacho FT, Anderson RT, Balkrishnan R.

J Prim Care Community Health. 2016 Jul;7(3):149-58. doi: 10.1177/2150131916632554. Epub 2016 Feb 23.

25.

What Predicts an Advanced-Stage Diagnosis of Breast Cancer? Sorting Out the Influence of Method of Detection, Access to Care, and Biologic Factors.

Lipscomb J, Fleming ST, Trentham-Dietz A, Kimmick G, Wu XC, Morris CR, Zhang K, Smith RA, Anderson RT, Sabatino SA; Centers for Disease Control and Prevention National Program of Cancer Registries Patterns of Care Study Group.

Cancer Epidemiol Biomarkers Prev. 2016 Apr;25(4):613-23. doi: 10.1158/1055-9965.EPI-15-0225. Epub 2016 Jan 27.

26.

Effects of Hospital Type and Distance on Lymph Node Assessment for Colon Cancer Among Metropolitan and Nonmetropolitan Patients in Appalachia.

Short PF, Moran JR, Yang TC, Camacho F, Gusani NJ, Mackley HB, Matthews SA, Anderson RT.

Med Care Res Rev. 2016 Oct;73(5):546-64. doi: 10.1177/1077558715619052. Epub 2015 Nov 27.

27.

Influence of patient, physician, and hospital characteristics on the receipt of guideline-concordant care for inflammatory breast cancer.

Denu RA, Hampton JM, Currey A, Anderson RT, Cress RD, Fleming ST, Lipscomb J, Sabatino SA, Wu XC, Wilson JF, Trentham-Dietz A.

Cancer Epidemiol. 2016 Feb;40:7-14. doi: 10.1016/j.canep.2015.11.003. Epub 2015 Nov 21.

28.

Intensity of anxiety is modified via complex integrative stress circuitries.

Smith JP, Prince MA, Achua JK, Robertson JM, Anderson RT, Ronan PJ, Summers CH.

Psychoneuroendocrinology. 2016 Jan;63:351-61. doi: 10.1016/j.psyneuen.2015.10.016. Epub 2015 Oct 24.

29.

Adjuvant therapy use among Appalachian breast cancer survivors.

Tan X, Marshall VD, Anderson RT, Donohoe J, Camacho F, Balkrishnan R.

Medicine (Baltimore). 2015 Jul;94(26):e1071. doi: 10.1097/MD.0000000000001071.

30.

The Hand-Foot Skin Reaction and Quality of Life Questionnaire: An Assessment Tool for Oncology.

Anderson RT, Keating KN, Doll HA, Camacho F.

Oncologist. 2015 Jul;20(7):831-8. doi: 10.1634/theoncologist.2014-0219. Epub 2015 Jun 17.

31.

Diabetes management before and after cancer diagnosis: missed opportunity.

Yao N, Camacho FT, Chukmaitov AS, Fleming ST, Anderson RT.

Ann Transl Med. 2015 Apr;3(5):72. doi: 10.3978/j.issn.2305-5839.2015.03.52.

32.

Bandgap Tuning of Silicon Quantum Dots by Surface Functionalization with Conjugated Organic Groups.

Zhou T, Anderson RT, Li H, Bell J, Yang Y, Gorman BP, Pylypenko S, Lusk MT, Sellinger A.

Nano Lett. 2015 Jun 10;15(6):3657-63. doi: 10.1021/nl504051x. Epub 2015 May 18.

PMID:
25971956
33.

XactMice: humanizing mouse bone marrow enables microenvironment reconstitution in a patient-derived xenograft model of head and neck cancer.

Morton JJ, Bird G, Keysar SB, Astling DP, Lyons TR, Anderson RT, Glogowska MJ, Estes P, Eagles JR, Le PN, Gan G, McGettigan B, Fernandez P, Padilla-Just N, Varella-Garcia M, Song JI, Bowles DW, Schedin P, Tan AC, Roop DR, Wang XJ, Refaeli Y, Jimeno A.

Oncogene. 2016 Jan 21;35(3):290-300. doi: 10.1038/onc.2015.94. Epub 2015 Apr 20.

34.

Adherence to adjuvant endocrine therapy for breast cancer: importance in women with low income.

Ursem CJ, Bosworth HB, Shelby RA, Hwang W, Anderson RT, Kimmick GG.

J Womens Health (Larchmt). 2015 May;24(5):403-8. doi: 10.1089/jwh.2014.4982. Epub 2015 Apr 17. Review.

PMID:
25884292
35.

Finalizing a measurement framework for the burden of treatment in complex patients with chronic conditions.

Eton DT, Ridgeway JL, Egginton JS, Tiedje K, Linzer M, Boehm DH, Poplau S, Ramalho de Oliveira D, Odell L, Montori VM, May CR, Anderson RT.

Patient Relat Outcome Meas. 2015 Mar 27;6:117-26. doi: 10.2147/PROM.S78955. eCollection 2015.

36.

Receipt of Regular Primary Care and Early Cancer Detection in Appalachia.

Camacho F, Hwang W, Kern T, Anderson RT.

J Rural Health. 2015 Summer;31(3):269-81. doi: 10.1111/jrh.12097. Epub 2014 Nov 4.

PMID:
25370354
37.

Patterns of locoregional treatment for nonmetastatic breast cancer by patient and health system factors.

Anderson RT, Morris CR, Kimmick G, Trentham-Dietz A, Camacho F, Wu XC, Sabatino SA, Fleming ST, Lipscomb J.

Cancer. 2015 Mar 1;121(5):790-9. doi: 10.1002/cncr.29092. Epub 2014 Nov 4.

38.

Hedgehog signaling drives radioresistance and stroma-driven tumor repopulation in head and neck squamous cancers.

Gan GN, Eagles J, Keysar SB, Wang G, Glogowska MJ, Altunbas C, Anderson RT, Le PN, Morton JJ, Frederick B, Raben D, Wang XJ, Jimeno A.

Cancer Res. 2014 Dec 1;74(23):7024-36. doi: 10.1158/0008-5472.CAN-14-1346. Epub 2014 Oct 8.

39.

Individual, Area, and Provider Characteristics Associated With Care Received for Stages I to III Breast Cancer in a Multistate Region of Appalachia.

Kimmick GG, Camacho F, Mackley HB, Kern T, Yao N, Matthews SA, Fleming S, Lipscomb J, Liao J, Hwang W, Anderson RT.

J Oncol Pract. 2015 Jan;11(1):e9-e18. doi: 10.1200/JOP.2014.001397. Epub 2014 Sep 16.

40.

The influence of diabetes severity on receipt of guideline-concordant treatment for breast cancer.

Sabatino SA, Thompson TD, Wu XC, Fleming ST, Kimmick GG, Trentham-Dietz A, Cress R, Anderson RT.

Breast Cancer Res Treat. 2014 Jul;146(1):199-209. doi: 10.1007/s10549-014-2998-3. Epub 2014 Jun 5.

41.

Effectiveness of the Chest Pain Choice decision aid in emergency department patients with low-risk chest pain: study protocol for a multicenter randomized trial.

Anderson RT, Montori VM, Shah ND, Ting HH, Pencille LJ, Demers M, Kline JA, Diercks DB, Hollander JE, Torres CA, Schaffer JT, Herrin J, Branda M, Leblanc A, Hess EP.

Trials. 2014 May 10;15:166. doi: 10.1186/1745-6215-15-166.

42.

Does rurality influence treatment decisions in early stage laryngeal cancer?

Mackley HB, Teslova T, Camacho F, Short PF, Anderson RT.

J Rural Health. 2014 Fall;30(4):406-11. doi: 10.1111/jrh.12069. Epub 2014 Mar 21.

PMID:
24654995
43.

Peering into the black box: a meta-analysis of how clinicians use decision aids during clinical encounters.

Wyatt KD, Branda ME, Anderson RT, Pencille LJ, Montori VM, Hess EP, Ting HH, LeBlanc A.

Implement Sci. 2014 Feb 22;9:26. doi: 10.1186/1748-5908-9-26.

44.

Women's values in contraceptive choice: a systematic review of relevant attributes included in decision aids.

Wyatt KD, Anderson RT, Creedon D, Montori VM, Bachman J, Erwin P, LeBlanc A.

BMC Womens Health. 2014 Feb 13;14(1):28. doi: 10.1186/1472-6874-14-28. Review.

45.

Comorbidity burden and guideline-concordant care for breast cancer.

Kimmick G, Fleming ST, Sabatino SA, Wu XC, Hwang W, Wilson JF, Lund MJ, Cress R, Anderson RT; Centers for Disease Control and Prevention National Program of Cancer Registry Patterns of Care Study Group.

J Am Geriatr Soc. 2014 Mar;62(3):482-8. doi: 10.1111/jgs.12687. Epub 2014 Feb 10.

46.

Phase I study of oral rigosertib (ON 01910.Na), a dual inhibitor of the PI3K and Plk1 pathways, in adult patients with advanced solid malignancies.

Bowles DW, Diamond JR, Lam ET, Weekes CD, Astling DP, Anderson RT, Leong S, Gore L, Varella-Garcia M, Vogler BW, Keysar SB, Freas E, Aisner DL, Ren C, Tan AC, Wilhelm F, Maniar M, Eckhardt SG, Messersmith WA, Jimeno A.

Clin Cancer Res. 2014 Mar 15;20(6):1656-65. doi: 10.1158/1078-0432.CCR-13-2506. Epub 2014 Feb 3.

47.

Clinical and Demographic Factors Associated With Receipt of Non Guideline-concordant Initial Therapy for Nonmetastatic Prostate Cancer.

Hamilton AS, Fleming ST, Wang D, Goodman M, Wu XC, Owen JB, Lo M, Ho A, Anderson RT, Thompson T.

Am J Clin Oncol. 2016 Feb;39(1):55-63. doi: 10.1097/COC.0000000000000017.

48.

Breast cancer screening, area deprivation, and later-stage breast cancer in Appalachia: does geography matter?

Anderson RT, Yang TC, Matthews SA, Camacho F, Kern T, Mackley HB, Kimmick G, Louis C, Lengerich E, Yao N.

Health Serv Res. 2014 Apr;49(2):546-67. doi: 10.1111/1475-6773.12108. Epub 2013 Sep 30.

49.

Psychometric evaluation of the hepatitis C virus patient-reported outcomes (HCV-PRO) instrument: validity, responsiveness, and identification of the minimally important difference in a phase 2 clinical trial.

Anderson RT, Baran RW, Erickson P, Revicki DA, Dietz B, Gooch K.

Qual Life Res. 2014 Apr;23(3):877-86. doi: 10.1007/s11136-013-0519-1. Epub 2013 Sep 14.

PMID:
24036634
50.

Development and initial psychometric evaluation of the hepatitis C virus-patient-reported outcomes (HCV-PRO) instrument.

Anderson RT, Baran RW, Dietz B, Kallwitz E, Erickson P, Revicki DA.

Qual Life Res. 2014 Mar;23(2):561-70. doi: 10.1007/s11136-013-0505-7. Epub 2013 Sep 5.

PMID:
24005885

Supplemental Content

Loading ...
Support Center